en · de · es · fr · pt
melanotan-2-notes.peptides9002.com › Wiki › Analytical Methods And Storage Stability — Quick Reference

Analytical Methods And Storage Stability — Quick Reference

By Editorial Desk · published 2025-09-19 · last reviewed 2025-11-04 · Wiki

If you have been reading about Related impurities and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2025-11-04. Numbers and descriptions here follow the published literature rather than marketing material.

Analytical Methods And Storage Stability

Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.

Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.

Chemistry and Receptor Pharmacology

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Melanotan-2 at a glance

PropertyValueNotes
AppearanceWhite to off-white solidLyophilised cake or flake
Solubility classSoluble in water and aqueous bufferAlso soluble in some polar organic solvents
Typical storage temperatureMinus 20 degrees Celsius or belowDesiccated and protected from light
Typical analytical methodLC-MS/MSReversed-phase separation with mass detection
Molecular formulaC50H69N15O9Free base; salt forms differ

Regulatory Status and Analytical Detection

Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.

The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.

Related pages on this site

Background and Chemical Profile

Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.

The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.

Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.

Regulation, Literature and Verification

Because the substance circulates mainly through informal markets, verification is a recurring theme in technical discussion. Independent analyses have found that labeled content and actual content can diverge, and that purity varies between samples. Analytical laboratories use reversed-phase chromatography to separate components and mass spectrometry to confirm identity. Isotope-labeled internal standards improve quantification in complex matrices. Such methods describe what a sample contains but say nothing about its sterility, lawful status, or suitability for any use. Open questions remain about how consistently testing is applied across the supply chain.

Regulatory treatment of this peptide varies by country. It holds no marketing authorization as a medicine in the United States, the European Union, or most other jurisdictions. Some countries classify products containing it as prescription-only or unlicensed medicines, which restricts lawful supply. Authorities have issued public notices warning that unregulated products may contain undeclared or incorrect ingredients. The molecule also appears on prohibited lists for competitive sport. These measures address supply oversight rather than any approved therapeutic role.

Published research on the compound remains limited. Much of the human data comes from small, early-stage studies rather than large controlled trials, and several questions about effects and variability between individuals remain open. Investigators have examined receptor activity, pigment pathways, and related physiological responses in laboratory and animal models. Findings from those models do not automatically translate to human outcomes. Reviews frequently note the scarcity of rigorous clinical evidence and call for better-characterized study material.

Melanotan-2 Structure and Receptor Pharmacology

No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.

Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.

Reference notes

== Bromine-75 == Bromine-75 has a half-life of 97 minutes. This isotope undergoes positron emission rather than electron capture about 76% of the time, so it was used for diagnosis and positron emission tomography (PET) in the 1980s. However, its decay product, selenium-75, produces secondary radioactivity with a longer half-life of around 120 days.

=== Feud with the House and Marcos-Duterte rift === A rift between the Duterte and Marcos families had begun under House Speaker Martin Romualdez' leadership. In the House of Representatives, unconfirmed reports of Deputy House Speaker Gloria-Macapagal Arroyo allegedly attempting to unseat Romualdez as House Speaker circulated. Despite Arroyo dismissing the accusations, Arroyo was later demoted by the House from her senior deputy Speaker position. Duterte's daughter, Vice President and Education Secretary Sara, subsequently resigned from the Romualdez-led Lakas-CMD and, in a veiled reference to Romualdez, called him a "tambaloslos" (A term that can be interpreted as a joke or as an insult, depending on context). In October 2023, Sara requested Congress for the allocation of confidential funds for the office of the vice president (OVP) and the education department which can be used for the Reserve Officers' Training Corps program. Her requests came under intense scrutiny by the Senate and the House, which was dominated by Romualdez's allies. Congress ultimately rejected her appeals while swiftly approving the confidential funds of the Office of the President; Sara eventually dropped her requests, reasoning that the move was being "divisive". In the aftermath of events, Duterte criticized the House for denying his daughter's confidential funds; alleging a collusion between Romualdez and the left-wing Makabayan bloc, he demanded an audit of the House under Romualdez.

For example, many compounds used for medication are weak acids or bases, and a knowledge of the pKa values, together with the octanol-water partition coefficient, can be used for estimating the extent to which the compound enters the blood stream. Acid dissociation constants are also essential in aquatic chemistry and chemical oceanography, where the acidity of water plays a fundamental role. In living organisms, acid–base homeostasis and enzyme kinetics are dependent on the pKa values of the many acids and bases present in the cell and in the body. In chemistry, a knowledge of pKa values is necessary for the preparation of buffer solutions and is also a prerequisite for a quantitative understanding of the interaction between acids or bases and metal ions to form complexes. Experimentally, pKa values can be determined by potentiometric (pH) titration, but for values of pKa less than about 2 or more than about 11, spectrophotometric or NMR measurements may be required due to practical difficulties with pH measurements.

Pakistan's nuclear policy became fixated on India because India refused to join the Non-proliferation Treaty and remained open to nuclear weapons. Impetus by Indian actions spurred Pakistan's nuclear research. After nuclear weapons construction was started by President Zulfikar Ali Bhutto's command, the chair of Pakistan Atomic Energy Commission Usmani quit in objection. The 1999 war between Pakistan and India occurred after both acquired nuclear weapons. It is believed by some that nuclear weapons are the reason a big war has not broken out in the subcontinent. India and Pakistan still have a risk of nuclear conflict on the issue of war over Kashmir. Nuclear capability deliverable by sea were claimed by Pakistan in 2012. The aim was to achieve a "minimum credible deterrence". Pakistan's nuclear program culminated in the tests at Chagai. One of the aims of Pakistan's programs is fending off potential annexation and maintaining independence. A key development in nuclear warfare throughout the 2000s and early 2010s is the proliferation of nuclear weapons to the developing world, with India and Pakistan both publicly testing several nuclear devices, and North Korea conducting an underground nuclear test on October 9, 2006. The U.S. Geological Survey measured a 4.2 magnitude earthquake in the area where the North Korean test is said to have occurred. A further test was announced by the North Korean government on May 25, 2009.

Sources: en.wikipedia.org

Reference notes

The Edman degradation is an alternative method for peptide sequencing that cleaves amino acid residues from the N-terminus of a peptide. In 1950 Edman designed a reaction with phenylthiocyanate (the idea for which was borrowed from a 1927 study by Bergmann, Kann and Miekeley ) to give phenylthiocarbamyl peptides followed by hydrolysis under relatively mild conditions to cleave N-terminal amino acid as phenylthiohydantoin. Phenylthiohydantoin is stable enough to undergo various sequencing procedures such as those which involve chromatography and mass spectrometry. This was an improvement on an earlier method proposed by Abderhalden and Brockmann in 1930 that demonstrated N-terminal amino acid conversion to a hydantoin under stronger hydrolytic conditions, where some cleavage of the residual peptide proved problematic. The primary advantage the Edman degradation has over the Bergmann degradation is the ease with which the residual peptide can re-enter the process due to retention of its structure throughout sequential cleaving. Repetition of the Bergmann degradation is presumably not as straightforward, as the remaining peptide is in amide form.

An added advantage of the prussian blue is that the caesium which is stripped from the animal in the droppings is in a form which is not available to plants. Hence it prevents the caesium from being recycled. The form of prussian blue required for the treatment of animals, including humans is a special grade. Attempts to use the pigment grade used in paints have not been successful.

==== Legal definitions ==== The International Organization for Standardization describes an AI system as a "an engineered system that generates outputs such as content, forecasts, recommendations, or decisions for a given set of human‑defined objectives, and can operate with varying levels of automation". The EU AI Act defines an AI system as "a machine-based system that is designed to operate with varying levels of autonomy and that may exhibit adaptiveness after deployment, and that, for explicit or implicit objectives, infers, from the input it receives, how to generate outputs such as predictions, content, recommendations, or decisions that can influence physical or virtual environments". In the United States, influential but non‑binding guidance such as the National Institute of Standards and Technology's AI Risk Management Framework describes an AI system as "an engineered or machine-based system that can, for a given set of objectives, generate outputs such as predictions, recommendations, or decisions influencing real or virtual environments. AI systems are designed to operate with varying levels of autonomy".

Sources: en.wikipedia.org

Reference notes

== Human spaceflight, space treaties, interplanetary probes (1961–1968) == The period from 1961 to 1968 began with the first men sent to space, the first robotic explorations of other planets; with missions to Venus and Mars conducted by both the Soviet Union and the United States, robotic landings on the Moon, and the gestation of US ambition to land a man on the Moon. The 1960s saw significant advancements in crewed spaceflight by both Cold War adversaries, as well as the first nuclear detonation in space, research into anti-satellite technology, and the signing of historic international outer space treaties.

In Pakistan, all sexual activity outside of marriage is illegal. The punishment for sex outside marriage (zina) ranges from up to five years' imprisonment for minors to 100 lashes for unmarried adults and stoning to death for married adults, depending on marital status, age, sanity, and whether strict evidentiary requirements for a hadd punishment—such as four adult male Muslim witnesses or a confession—are met; however, no one has been stoned to death under the law to date. Male homosexuality is illegal in Pakistan and is punishable by up to ten years in prison, corporal punishment such as whipping, and, under Islamic law since 1990, potentially even stoning. Honour killings, locally referred to as karo-kari in parts of Pakistan, involve the killing of women and, less frequently, men by family or community members over alleged extramarital relationships or perceived violations of honour. Human rights organisations report that hundreds of women are killed each year, with many cases unreported. Pakistan also has a high number of reported acid attacks, with about 200 incidents annually as of 2023, most victims being women. According to Masarrat Misbah, founder of the Depilex Smileagain Foundation, women have been targeted for rejecting marriage proposals, giving birth to daughters instead of sons, or insufficient dowry. The 2011 Acid and Burn Crime Bill criminalised acid attacks, making them punishable by lengthy imprisonment and fines. In parts of Pakistan, girls are given in marriage to settle disputes or crimes between families in a customary practice called Vani.

Carefully research the demand for their potential new product before spending an outlay of company funds. Obtain a patent on the new medicine preventing other companies from producing that medicine for a certain allocation of time. The Inverse Benefit Law describes the relationship between a drug's therapeutic benefits and the socioeconomic status (overall health risk/need) of the population undergoing treatment. The law states that the therapeutic benefit conferred by medical interventions upon a population is inversely proportional to its incidence of disease or socioeconomic need. When designing drugs, the placebo effect must be considered to assess the drug's true therapeutic value. Drug development uses techniques from medicinal chemistry to chemically design drugs. This overlaps with the biological approach of finding targets and physiological effects.

=== Limitation of the measurement method === Mass spectra alone lack sufficient information to unambiguously identify every molecule. Some molecules produce almost indistinguishable spectra – even more similar than the same molecule measured on two different instruments. Extensive follow-up experiments are required for unambiguous identification. Based thereon, it is impossible to always correctly identify a molecular structure merely from a mass spectrum. Thus, CSI:FingerID as well as other methods for structure database search, cannot guarantee finding the correct molecular structure as first hit. That is why it is important to have the correct structure ranked very high from an extensive list of candidates and to assess the confidence in the top hit.

Sources: en.wikipedia.org

Frequently asked questions

Which analytical technique is most informative for identity?

Mass spectrometry combined with liquid chromatography provides both molecular weight confirmation and a measure of related impurities. Tandem mass spectrometry adds sequence information. A purity percentage reported without a mass measurement does not confirm what the material is.

Does freeze-dried peptide keep indefinitely?

No. Lyophilisation slows degradation rather than stopping it, and the rate depends on residual moisture, temperature and light exposure. Freezer storage extends useful life but does not make the material permanent.

How much weight should a certificate of analysis carry?

A certificate is only as good as its traceability to a specific batch and a named laboratory. Documents lacking batch numbers, method descriptions or laboratory identifiers carry little weight. Confirming what was actually received generally requires a separate test of the material in hand.

Is melanotan II identical to alpha-melanocyte-stimulating hormone?

No. It is a synthetic analogue carrying four amino acid changes, a lactam ring and an amidated C-terminus. The natural hormone is a linear thirteen-amino-acid peptide processed from proopiomelanocortin.

Network